Entering text into the input field will update the search result below

Schrödinger gets $111.3M linked to Takeda's acquisition of Nimbus' psoriasis drug

Feb. 14, 2023 7:31 AM ETSchrödinger, Inc. (SDGR), TAKBy: Ravikash, SA News Editor1 Comment

Two unrecognizable businesswomen shaking hands after a meeting


  • Schrödinger (NASDAQ:SDGR) said it received $111.3M cash distribution from Nimbus Therapeutics, in connection with Takeda Pharmaceutical's (NYSE:TAK) acquisition of Nimbus Lakshmi.
  • In December 2022, Takeda agreed to pay $4B upfront to acquire Nimbus Lakshmi, a unit of Nimbus Therapeutics and its

Recommended For You

Comments (1)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Will double in price by 2024!

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.